首页 | 本学科首页   官方微博 | 高级检索  
检索        

肿瘤多药耐药的产生机制及逆转策略
引用本文:吴静,杨睿,刘树业.肿瘤多药耐药的产生机制及逆转策略[J].国外医学(肿瘤学分册),2013(12):889-892.
作者姓名:吴静  杨睿  刘树业
作者单位:[1]天津市第三中心医院检验科,300170 [2]天津医科大学基础医学研究中心转化肿瘤学实验室,300170
基金项目:国家自然科学基金(81301985)
摘    要:肿瘤多药耐药(MDR)是导致临床化疗失败和患者死亡的主要原因。研究表明,MDR的发生与P-糖蛋白、多药耐药相关蛋白、乳腺癌耐药相关蛋白、肺耐药相关蛋白等多种因素相关。目前MDR的逆转策略主要包括化学药物逆转、基因逆转、免疫逆转、中药逆转和纳米载药系统逆转,并且均取得了一定进展,这将有助于提高肿瘤患者的化疗疗效。

关 键 词:肿瘤  抗药性,多药  纳米技术

Mechanisms and reversal strategies of tumor multidrug resistance
WU Jing,YANG Rui,LIU Shu-ye.Mechanisms and reversal strategies of tumor multidrug resistance[J].Foreign Medical Sciences (Cancer Section),2013(12):889-892.
Authors:WU Jing  YANG Rui  LIU Shu-ye
Institution:. Department of Clinical Laboratory, Tianjin Third Central Hospital, Tianjin 300170, China
Abstract:Tumor muhidrug resistance (MDR) is the leading cause of clinical chemotherapy failure and death. Researches show that the occurrence of MDR is related to P-glycoprotein, muhidrug resistance-asso- ciated proteins, breast cancer resistance-associated proteins, lung resistance-related proteins and other factors. Now the reversal strategies of MDR include chemical drugs reversal, gene reversal, immune reversal, traditional Chinese medicine reversal and drug-loaded nano-system reversal, which make some progress and help to improve the effect of cancer chemotherapy.
Keywords:Neoplasms  Drug resistance  multiple  Nanotechnology
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号